Bell Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.53K | Hold |
43
| – | – | ﹤0.01% | 855 |
|
|
2025
Q1 | $6.47K | Buy |
43
+12
| +39% | +$1.81K | ﹤0.01% | 792 |
|
|
2024
Q4 | $5.72K | Sell |
31
-11
| -26% | -$2.03K | ﹤0.01% | 868 |
|
|
2024
Q3 | $8.27K | Sell |
42
-6
| -13% | -$1.18K | ﹤0.01% | 696 |
|
|
2024
Q2 | $9.92K | Hold |
48
| – | – | ﹤0.01% | 614 |
|
|
2024
Q1 | $13K | Sell |
48
-9
| -16% | -$2.44K | ﹤0.01% | 494 |
|
|
2023
Q4 | $13.5K | Buy |
57
+8
| +16% | +$1.89K | ﹤0.01% | 457 |
|
|
2023
Q3 | $9.6K | Sell |
49
-1
| -2% | -$196 | ﹤0.01% | 522 |
|
|
2023
Q2 | $10.5K | Buy |
50
+1
| +2% | +$210 | ﹤0.01% | 498 |
|
|
2023
Q1 | $9.89K | Sell |
49
-2
| -4% | -$404 | ﹤0.01% | 487 |
|
|
2022
Q4 | $11.1K | Buy |
51
+10
| +24% | +$2.18K | ﹤0.01% | 458 |
|
|
2022
Q3 | $8K | Sell |
41
-22
| -35% | -$4.29K | ﹤0.01% | 479 |
|
|
2022
Q2 | $13K | Buy |
+63
| New | +$13K | ﹤0.01% | 359 |
|
|
2021
Q4 | $16K | Sell |
43
-3
| -7% | -$1.12K | ﹤0.01% | 360 |
|
|
2021
Q3 | $19K | Buy |
+46
| New | +$19K | 0.01% | 294 |
|